🇺🇸 FDA
Pipeline program

Unesbulin

PTC596-ONC-008-LMS

Phase 3 small_molecule terminated

Quick answer

Unesbulin for Leiomyosarcoma is a Phase 3 program (small_molecule) at PTC THERAPEUTICS, INC. with 2 ClinicalTrials.gov record(s).

Program details

Company
PTC THERAPEUTICS, INC.
Indication
Leiomyosarcoma
Phase
Phase 3
Modality
small_molecule
Status
terminated

Clinical trials